Related Experiment Video
Updated: May 24, 2025
08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.0K
Inflamed Tissue-Targeting Polyphenol-Condensed Antioxidant Nanoparticles with Therapeutic Potential
Dohyub Jang1,2, Honghwan Choi2,3, Juhyang Lee4
1Department of Biomicrosystem Technology, Korea University, Seoul, 02792, Republic of Korea.
Advanced Healthcare Materials
|March 4, 2025
Summary
A novel nanotherapeutic, CCN150, derived from polyphenolic catechin, effectively targets inflamed tissues and reduces reactive oxygen species (ROS) to combat chronic inflammation with minimal toxicity.
Area of Science:
- Biomaterials Science
- Nanomedicine
- Inflammation Research
Background:
- Chronic inflammation drives multi-organ dysfunction via excessive reactive oxygen species (ROS) production.
- Polyphenol-based nanotherapeutics offer advantages in stability, targeting, and multifunctionality for treating inflammation.
- Developing biocompatible nanomedicines for selective accumulation in inflamed tissues and ROS inhibition is challenging.
Purpose of the Study:
- To engineer a novel anti-inflammatory nanotherapeutic from catechin via hydrothermal condensation.
- To evaluate the physicochemical properties, ROS scavenging ability, and in vivo efficacy of the nanotherapeutic (CCN150).
- To assess the biodistribution and toxicity profile of CCN150 for potential therapeutic applications.
Main Methods:
- Hydrothermal reactions were used to synthesize catechin-condensed nanotherapeutic (CCN150).
- Physicochemical properties, water solubility, and ROS elimination capabilities of CCN150 were assessed.
- In vivo studies in mouse models evaluated CCN150's biodistribution, anti-inflammatory effects, and toxicity.
Main Results:
- CCN150 exhibited enhanced water solubility compared to catechin while retaining its properties.
- CCN150 effectively eliminated intracellular ROS and augmented antioxidant enzymes, protecting cells from oxidative stress.
- Intravenously administered CCN150 selectively accumulated in inflamed tissues, reduced systemic inflammation in mouse models, and showed negligible toxicity.
Conclusions:
- CCN150, a novel catechin-derived nanotherapeutic, demonstrates potent anti-inflammatory and ROS-scavenging activities.
- Selective accumulation in inflamed tissues and a favorable safety profile make CCN150 a promising candidate for treating ROS-mediated inflammatory diseases.
